NYB is the Winner of SuperAI Genesis 2025

We’re thrilled to announce that NYB has been crowned the 1st Prize Winner of the SuperAI Genesis Startup Competition 2025, held at SuperAI Singapore, Asia’s largest AI event.

Held at SuperAI Singapore, Asia's largest AI event brings together the most exciting frontier technology startups, industry leaders, renowned researchers and innovators to shape the future of artificial intelligence.

Out of over 700+ startups across the region, NYB rose to the top at the world’s premier AI startup showdown, impressing judges from 500 Global, AWS Startups and Plug and Play Tech Center to win US$125k+ in prizes.

A Milestone for AI in Biotechnology

Winning this competition is more than just a milestone for our team, it’s a validation of our mission to transform drug discovery through the power of AI.

At NYB, we are building intelligent systems that accelerate drug discovery timelines from years to months, enabling faster, more targeted, and scalable therapeutic development. Our proprietary AI platform is designed specifically for health and wellness applications, where speed, accuracy, and innovation can lead to meaningful patient impact.

Duy Trieu, Director of Engineering, receiving the First Prize at SuperAI Genesis 2025

What Sets Our Platform Apart

Our platform combines cutting-edge AI models with high-performance computing tools to screen millions of natural compounds to identify top candidates at unprecedented speed and precision. Leveraging:

• NVIDIA NIMs

• CUDA

• BioNeMo

• TensorRT

We can reduce traditional compound screening and optimization timelines by up to 80%, helping researchers and healthcare innovators bring solutions to market faster than ever before.

This work is made possible in part through our participation in the NVIDIA Inception Program, an exclusive initiative designed to accelerate top AI startups that are pushing the boundaries of AI development. NYB is one of the only five startups in Asia - Pacific to be selected in this first batch, highlighting its leadership in AI-driven pharmaceutical research.

NYB at NVIDIA GTC Taipei 2025

A Global Mission, a Global Community

NYB is proud to serve clients around the world, from early-stage biotech firms to established health organizations looking to supercharge their R&D pipelines.

Our goal is simple but bold: To translate nature’s medicinal insights into scalable health and wellness solutions using AI.

By combining the power of advanced AI and natural compounds, we aim to deliver therapies that are not only faster to discover, but smarter, safer, and more sustainable.